Skip to content
CancerIndex

Publication

PCIF1-mediated m6Am modification activates USP5/BRD4 axis to promote glycolysis-driven immunosuppression in multiple myeloma.

Shifeng Long, Ting Ding, Lu Zhou, Weifang Gao, Qinglan Wang, Yan Liu

International immunopharmacologyOct 1, 2026PMID 42385640doi:10.1016/j.intimp.2026.117062 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Oct 1, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20261001-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Multiple myeloma (MM) is a malignant plasma cell disorder, with aberrant glycolysis being a key feature driving tumor progression and immune escape. PCIF1, an RNA modification-related protein, has been implicated in tumorigenesis, but its role in regulating MM progression remains…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.